Newsroom

CANTON, Mass.--(BUSINESS WIRE)--Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its 11 acute facilities and dozens of outpatient locations, enhancing patient safety and improving workflow efficiencies. The innovative, cloud-based EHR provides clinicians across all facilities with a unified, multi-disciplinary health record, giving them a seamless view of the patient's journey and health status whenever and wherever the patient receives c...

BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced that it secured 145 billion KRW (approximately US$100 million) in convertible preferred stock investments. This round is led by returning investor KB Investment and includes other existing investors, IMM Investment, Woori Venture Partners and Stassets Investment. New investors includ...

LIMASSOL, Cyprus--(BUSINESS WIRE)--iFOREX, a leading global fintech company operating a proprietary electronic trading platform, has expanded its offering to include CFDs on Saudi Arabian and South Korean shares. iFOREX clients can now trade CFDs on a broad range of leading Saudi stocks, featuring shares from 13 companies across diverse sectors, such as energy, technology, and finance – all listed on the Saudi Exchange. In addition, clients have access to top South Korean shares, further expand...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment...

SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), das führende Unternehmen im Bereich Konnektivitäts-Cloud, und JD Cloud, ein intelligenter Technologiedienstleister und Tochterunternehmen von JD.com, haben heute Pläne für eine bedeutende Ausweitung ihrer Partnerschaft bekannt gegeben, mit dem Ziel, eine globale Plattform zu schaffen, die Entwicklern die nahtlose Bereitstellung, Verwaltung und Skalierung von KI-Inferenz-Workloads ermöglicht. Das Wachstum KI-gesteuerter Anwendungen in...

SINGAPORE--(BUSINESS WIRE)--With reference to the stock exchange announcement published on 11 September 2025, Hafnia Limited ("Hafnia", the "Company", OSE ticker code: "HAFNI", NYSE ticker code: “HAFN”) today announces that all conditions precedent required for the completion of Hafnia's acquisition of approximately 14.1 million A-shares in TORM plc (“TORM”, CSE ticker code: “TRMD A“, NASDAQ ticker code: “TRMD”), from Oaktree Capital Management, L.P. and its affiliates (together, “Oaktree”) hav...

SAN FRANCISCO--(BUSINESS WIRE)--Farallon Capital Management L.L.C. ("Farallon") today released the results of a perception study of the shareholders and sell-side analysts of T&D Holdings Inc. ("T&D HD" or the “Company”) conducted by an independent global research firm (“Perception Study”). Farallon first became a shareholder of T&D HD in 2008 and has continued to engage constructively with T&D HD management and Board of Directors. Farallon has requested that the Company acceler...

サンフランシスコ--(BUSINESS WIRE)--（ビジネスワイヤ） -- ファラロン・キャピタル・マネジメントL.L.C.（以下「当社」）は、独立した第三者である世界的な大手グローバル調査会社に、T&Dホールディングス株式会社（以下「T&D HD」）に関する株主等意見調査（Perception Study、以下「本調査」）の実施を依頼しました。今般、当該調査会社が取りまとめた調査結果を公表いたします。 当社は2008年にT&D HDの株主となり、現在、T&D HDの経営陣および取締役会との継続的かつ建設的な対話を実施しております。このような対話の機会を得られていることに、深く感謝しております。当社は、T&D HDに対し、企業価値向上に向けた大胆な改革を遂行するとともに、経済価値ベースの指標をKPIに据えた『EV経営』を推進し、キャピタル・アロケーション戦略においても同様の観点を徹底することを求めています。 当社は、こうした対話を継続している中で、資本市場におけるT&D HDの客観的な評価を、同社の経営陣および取締役会に認識いただく...

TOKYO & MUNICH--(BUSINESS WIRE)--The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and...

CAMBRIDGE, England--(BUSINESS WIRE)--EDX Medical Group announces the commercial launch in the UK of a new comprehensive testing service that improves the early detection of bowel cancer....